摘要
目的:探讨子宫内膜癌中抗凋亡基因Bcl-2和细胞增殖活性指标ki-67的表达及其与临床病理因素和预后的关系。方法:采用SP法免疫组化染色石蜡包埋的子宫内膜癌组织。结果:61例子宫内膜癌中组织学分级Ⅰ级者较Ⅱ、Ⅲ级子宫内膜癌Bcl-2表达显著升高( P< 0.01),存活时间超过5年者较5年内死亡者的表达明显增加(P<0.05)。而各临床分期间,合并宫内膜增生与未合并宫内膜增生者间Bcl-2表达无明显差异( P> 0.05)。61例子宫内膜癌以单克隆抗体MIB-1代表的细胞增殖指数与组织学分级、临床分期均无关。但5年内死亡病例组的平均增殖指数明显高于存活时间超过5年者(P< 0.01)。Bcl-2与MIB-1在子宫内膜癌中的表达没有明显的相关性(P > 0.01)。结论:Bcl-2在从子宫内膜增生、非典型增生到癌的变化过程中逐渐减少,是一个重要的预后因素。
Objective:We investigated the expression of Bcl 2 and ki 67 in endometrial carcinoma and their relationships to clinico pathologic features and prognosis.Methods:Immunohistochemical staining was performed using a SP method.Bcl 2 monoclonal antibody and MIB 1(paraffin ki 67)monoclonal antibody was used respectively in the paraffin embedded specimens of endometrial carcinoma. Results:28 of 61 cases of endometrial carcinoma showed Bcl 2 reactivity with the positive rate of 45.9%.The reactivity of Bcl 2 correlated negatively with the grades of tumor(P<0.01). The group of disease free survival above 5 years has significantly higher expression than group of death within 5 years(P<0.05).There was no significant difference between Bcl 2 expression and clinical stage or with or without endometrial hyperplasia.The proliferative fraction with MIB 1 was 22.16%± 3.88% . It was not associated with histological grade or clinical stage. But the group of death within 5 years has higher expression than group of disease free survival above 5 years(P<0.01).Bcl 2 expression was not related with that of ki 67.Methods:Immunohistochemical staining was performed using a SP method.Bcl 2 monoclonal antibody and MIB 1(paraffin ki 67)monoclonal antibody was used respectively in the paraffin embedded specimens of endometrial carcinoma. Results:28 of 61 cases of endometrial carcinoma showed Bcl 2 reactivity with the positive rate of 45.9%.The reactivity of Bcl 2 correlated negatively with the grades of tumor(P<0.01). The group of disease free survival above 5 years has significantly higher expression than group of death within 5 years(P<0.05).There was no significant difference between Bcl 2 expression and clinical stage or with or without endometrial hyperplasia.The proliferative fraction with MIB 1 was 22.16%± 3.88% . It was not associated with histological grade or clinical stage. But the group of death within 5 years has higher expression than group of disease free survival above 5 years(P<0.01).Bcl 2 expression was not related with that of ki 67.Immunohistochemical staining was performed using a SP method.Bcl 2 monoclonal antibody and MIB 1(paraffin ki 67)monoclonal antibody was used respectively in the paraffin embedded specimens of endometrial carcinoma. Results:28 of 61 cases of endometrial carcinoma showed Bcl 2 reactivity with the positive rate of 45.9%.The reactivity of Bcl 2 correlated negatively with the grades of tumor(P<0.01). The group of disease free survival above 5 years has significantly higher expression than group of death within 5 years(P<0.05).There was no significant difference between Bcl 2 expression and clinical stage or with or without endometrial hyperplasia.The proliferative fraction with MIB 1 was 22.16%± 3.88% . It was not associated with histological grade or clinical stage. But the group of death within 5 years has higher expression than group of disease free survival above 5 years(P<0.01).Bcl 2 expression was not related with that of ki 67.Results:28 of 61 cases of endometrial carcinoma showed Bcl 2 reactivity with the positive rate of 45.9%.The reactivity of Bcl 2 correlated negatively with the grades of tumor(P<0.01). The group of disease free survival above 5 years has significantly higher expression than group of death within 5 years(P<0.05).There was no significant difference between Bcl 2 expression and clinical stage or with or without endometrial hyperplasia.The proliferative fraction with MIB 1 was 22.16%± 3.88% . It was not associated with histological grade or clinical stage. But the group of death within 5 years has higher expression than group of disease free survival above 5 years(P<0.01).Bcl 2 expression was not related with that of ki 67.Conclusion: The expression of Bcl 2 gradually decreased from endometrial hyperplasia, atypical hyperplasia to endometrial carcinoma. It was an important prognostic factor. ki 67 also plays an important role in prognosis.
出处
《中国医科大学学报》
CAS
CSCD
北大核心
1999年第5期384-386,共3页
Journal of China Medical University